Document:

THIS
SUBSCRIPTION AGREEMENT RELATES TO AN OFFERING OF SHARES OF SERIES A CONVERTIBLE PREFERRED STOCK IN AN OFFSHORE TRANSACTION TO
PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED HEREIN) PURSUANT TO REGULATION S PROMULGATED BY THE UNITED STATES SECURITIES AND
EXCHANGE COMMISSION (THE “SEC”) UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”).

 

THE
SHARES THAT ARE SUBJECT TO THIS SUBSCRIPTION AGREEMENT IN RELIANCE ON REGULATION S (THE “SUBSCRIPTION AGREEMENT”)
HAVE NOT BEEN REGISTERED UNDER THE ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD,
DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO U.S. PERSONS (AS DEFINED HEREIN) EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF
REGULATION S UNDER THE ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN ACCORDANCE WITH
THE ACT.

 

TECHCARE
CORP. 

(A
Delaware corporation)

 

SUBSCRIPTION
AGREEMENT

 

DATED:
August __, 2019 (the “Effective Date”)

 

1.
The Subscription

 

1.1
On the basis of the representations and warranties and subject to the terms and conditions set forth in this Subscription Agreement,
___________ (the “Investor”) hereby agrees to subscribe for and purchase 4,137,931 shares (the “Initial
Shares”) of Series A Convertible Preferred Stock, par value $0.0001, issued hereunder having the rights, preferences
and privileges set forth in the Certificate of Designation, in the form of Exhibit A hereto (the “Preferred Stock”),
offered by TechCare Corp., a Delaware corporation with offices located at 1140 Avenue of the Americas, New York, NY 10036 (the
“Company”), at a purchase price per share of $0.029 (the “Share Purchase Price”), for an
aggregate consideration of $120,000 (the “Subscription Proceeds”), all pursuant to the terms and conditions
set forth in this Subscription Agreement.

 

1.2
In addition, on the basis of the representations and warranties and subject to the terms and conditions set forth in this Subscription
Agreement, the Investor shall be entitled, until the 12 month anniversary of the Effective Date, to subscribe for, and purchase,
200,000 additional shares of the Company’s Preferred Stock (the “Additional Shares” and together with
the Initial Shares, the “Shares”) at a purchase price per share of $0.60, for an aggregate consideration of
$120,000 (the “Additional Subscription Proceeds”), all pursuant to the terms and conditions set forth in this
Subscription Agreement.

 

1.3
The undersigned Investor understands that the offering by the Company under this Subscription Agreement is being made only to
persons/institutions who are not U.S. Persons, as defined in Rule 902 of Regulation S promulgated by the SEC under the Act and
that the Company will not offer Shares nor accept subscriptions from any person and/or entity that is a U.S. Person as defined
in Rule 902 of Regulation S.

 

1.4
On the basis of the representations and warranties of the Investor and subject to the terms and conditions set forth herein, the
Company, by its execution and delivery of the counter-signed copy of this Subscription Agreement, hereby irrevocably agrees to
accept the subscription and sell to the Investor the Shares subscribed for herein.

 

1.5
Subject to the terms hereof, the offer and sale of the Shares under this Subscription Agreement will be effective only upon receipt
by the Company of the Subscription Proceeds.

 

1.6
Within seven (7) days of from the receipt of the Subscription Proceeds or the Additional Subscription Proceeds by the Company,
as applicable, the Company shall deliver to the Investor book entry confirmation representing the number of Shares purchased by
the Investor. The Shares shall be registered on the books of the Company as follows: _________.

 

    	 

    	 

    

 

2.
Payment of Subscription Proceeds and Additional Subscription Proceeds

 

The
Investor understands that the Subscription Proceeds and Additional Subscription Proceeds, as applicable, are payable to the Company
by electronic wire transfer pursuant to the Company’s wiring instructions to be provided thereto.

 

3.
Documents/Deliveries Required from the Investor

 

3.1
The Investor understands and agrees that as a condition to the Company’s acceptance of this subscription, the undersigned
will complete, sign and return to the Company an executed copy of this Subscription Agreement together with any and all attachments
hereto.

 

3.2
The Investor will complete, sign and return to the Company as soon as possible, on request by the Company, any other documents,
questionnaires, notices and undertakings as may be reasonably required by regulatory authorities and applicable law.

 

3.3
The Investor will pay/deliver the Subscription Proceeds and the Additional Subscription Proceeds, as applicable, to the Company
as provided in Section 2 above subject to the Company’s execution and acceptance of this Subscription Agreement.

 

4.
Acknowledgements of Investor

 

4.1
The Investor acknowledges and agrees that:

 

(i)
the Shares being offered have not been registered under the Act, or under any state securities or “blue sky” laws
of any state of the United States, and, unless so registered, the Shares may neither be offered nor sold in the United States
or, directly or indirectly, to U.S. Persons, as that term is defined in Rule 902 of Regulation S under the Act, except in accordance
with the provisions of Regulation S, pursuant to an effective registration statement under the Act, or pursuant to an exemption
from, or in a transaction not subject to, the registration requirements of the Act;

 

(ii)
the Investor acknowledges that the Company has not undertaken, and will have no obligation, to register the Shares under the Act;

 

(iii)
the decision to execute this Subscription Agreement has not been based upon any oral or written representation as to fact or otherwise
made by or on behalf of the Company, and such decision is based entirely upon a review of information (the receipt of which is
hereby acknowledged) which has been filed by the Company with the SEC under the Securities Exchange Act of 1934 (collectively,
the “Exchange Act Reports”);

 

(iv)
no securities commission or similar regulatory authority has reviewed or passed on the merits of an investment in the Shares;

 

(v)
there is no government or other insurance covering any investment in the Shares;

 

(vi)
there are risks associated with an investment in the Shares, as more fully described in certain information forming part of the
Exchange Act Reports;

 

(vii)
the Investor has had a reasonable opportunity to ask questions of and receive answers from the Company in connection with this
subscription and to obtain additional information, to the extent possessed or obtainable without unreasonable effort or expense,
necessary to verify the accuracy of the information about the Company;

 

(viii)
the books and records of the Company were available upon reasonable notice for inspection, subject to certain confidentiality
restrictions, by the Investor during reasonable business hours at its principal place of business, and all documents, records
and books in connection with the distribution of the Shares hereunder have been made available for inspection by the Investor,
the Investor’s attorney and/or advisor(s), if any;

 

    	 

    	 

    

 

(ix)
there is no guarantee that the Shares will be listed on any stock exchange or automated dealer quotation system and no representation
has been made to the Investor that the Shares will be listed on any stock exchange or automated dealer quotation system;

 

(x)
the Shares are assignable only with the prior written consent of the Company, which consent will not be unreasonably denied, provided
that any such transfer is made in accordance with the provisions of Regulation S, pursuant to an effective registration statement
under the Act or pursuant to an available exemption from the registration requirements of the Act; and

 

(xi)
this Subscription Agreement is not enforceable by the Investor unless it has been accepted by the Company.

 

5.
Representations, Warranties and Covenants of the Investor

 

5.1
The Investor hereby represents and warrants to and covenants with the Company (which representations, warranties and covenants
shall be true and correct as of the date hereof and as of the subscription date of the Additional Shares, and will survive the
execution and delivery of this Subscription Agreement) that:

 

(i)
the Investor has the legal capacity and competence to enter into and execute this Subscription Agreement and to take all actions
required pursuant hereto and, if the Investor is a corporation, it is duly incorporated and validly subsisting under the laws
of its jurisdiction of incorporation and all necessary approvals by its directors, shareholders and others have been obtained
to authorize execution and performance of this Subscription Agreement on behalf of the Investor;

 

(ii)
entering into this Subscription Agreement and the transactions contemplated hereby do not result in the violation of any of the
terms and provisions of any law applicable to, or the corporate documents of, the Investor or of any agreement, written or oral,
to which the Investor may be a party or by which the Investor is or may be bound;

 

(iii)
the Investor has duly executed and delivered this Subscription Agreement and it constitutes a valid and binding agreement of the
Investor enforceable against the Investor;

 

(iv)
the Investor is not a U.S. Person, as that term is defined in Rule 902 of Regulation S under the Act;

 

(v)
the Investor is not acquiring the Shares for the account or benefit of, directly or indirectly, any U.S. Person, as that term
is defined in Rule 902 of Regulation S under the Act;

 

(vi)
the Investor is resident of the jurisdiction set out under the heading “Name and Address of Investor” on the signature
page of this Subscription Agreement;

 

(vii)
the Investor is and will be outside the United States when receiving and executing this Subscription Agreement and is acquiring
the Shares as principal for the Investor’s own account (except for the circumstances outlined in paragraph 5.1), for investment
purposes only, and not with a view to, or for, resale, distribution or fractionalization thereof, in whole or in part, and no
other person has a direct or indirect beneficial interest in the Shares;

 

(ix)
the Investor is acquiring the Shares for investment only and not with a view to resale or distribution and, in particular, it
has no intention to distribute either directly or indirectly any of the Shares in the United States or to U.S. Persons;

 

(x)
the Investor is not an underwriter of, or dealer in, the Shares of the Company, nor is the Investor participating, pursuant to
a contractual agreement or otherwise, in the distribution of the Shares;

 

(xi)
the Investor:

 

(a)
is able to fend for itself in connection with the offer and sale of Shares under this Subscription Agreement; and

 

    	 

    	 

    

 

(b)
has such knowledge and experience in business matters as to be capable of evaluating the merits and risks of its prospective investment
in the Company’s Shares offered hereby; and

 

(c)
has the ability to bear the economic risks of its prospective investment and can afford the complete loss of such investment;

 

(xii)
if the Investor is acquiring the Shares as a fiduciary or agent for one or more investor accounts, the Investor has sole investment
discretion with respect to each such account and it has full power to make the foregoing acknowledgements, representations and
agreements on behalf of such account, and the investor accounts, if any, for which the Investor acts as a fiduciary or agent satisfy
the definition of an “Accredited Investor,” as the term is defined in Rule 501 of Regulation D under the Act;

 

(xiii)
the Investor acknowledges that the Investor has not acquired the Shares as a result of, and will not itself engage in, any “directed
selling efforts” (as defined in Regulation S under the Act) in the United States in respect of any of the Shares which would
include any activities undertaken for the purpose of, or that could reasonably be expected to have the effect of, conditioning
the market in the United States for the resale of any of the Shares, provided, however, that the Investor may sell or otherwise
dispose of any of the Shares pursuant to an effective registration statement under the Act and any applicable state securities
laws or under an exemption from such registration requirements and as otherwise provided herein;

 

(xiv)
the Investor has not received nor is he aware of any advertisement or public solicitation pertaining to the offer or sale of any
of the Shares; and

 

(xv)
no person has made to the Investor any written or oral representations that:

 

(a)
any person will resell or repurchase any of the Shares; and

 

(b)
any person will refund the purchase price of any of the Shares paid by the Investor pursuant to this Subscription Agreement.

 

6.
Conditions Precedent. 

 

The
undertaking of the Investor shall be subject to and contingent upon the following:

 

6.1
Prior to the Effective Date, the Company shall have secured all permits, consents and authorizations that shall be necessary or
required lawfully to consummate this Subscription Agreement and to issue Shares in accordance with the terms of this Subscription
Agreement. The Company has all requisite corporate power to own and operate its property and assets, to perform all its obligations
under all agreements and instruments to which it is a party or by which it is bound, and to carry on the business of the Company
as presently conducted and as proposed to be conducted. The Company is in compliance with all applicable laws, including all laws
pertaining to it as a public company. All issued and outstanding shares of the Company have been duly authorized, and are validly
issued and outstanding and fully paid and non-assessable. The Shares, when issued in accordance with this Subscription Agreement,
will be duly authorized, validly issued, fully paid, non-assessable, and free of any preemptive rights, and will have the rights,
preferences, privileges, and restrictions set forth in the Certificate of Incorporation of the Company, and will be issued free
and clear of any liens, claims, encumbrances or third party rights of any kind and duly registered in the name of the Investor
in the Company’s register of members.

 

6.2
The Company has duly executed and delivered this Subscription Agreement and it constitutes a valid and binding agreement of the
Investor enforceable against the Investor.

 

6.3
The acquisition of and subscription for the Shares by the Investor as contemplated in this Subscription Agreement complies with
or is exempt from the applicable securities legislation of the jurisdiction of residence of the Investor.

 

6.4
As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free
of preemptive rights, a sufficient number of shares of the Company’s shares of common stock, par value $0.0001 per share,
for the purpose of enabling the Company to issue the Shares pursuant to this Subscription Agreement and conversion of the Preferred
Stock.

 

    	 

    	 

    

 

7.
Acknowledgement and Waiver

 

The
Investor hereby acknowledges that the decision to subscribe for and purchase the Shares has been made solely on the basis of publicly
available information contained in the Exchange Act Reports. The Investor hereby waives, to the fullest extent permitted by law,
any rights of withdrawal, rescission or compensation for damages to which the Investor might be entitled in connection with the
distribution of any of the Shares.

 

8.
Restrictive Legend on Subject Securities

 

8.1
The Investor hereby acknowledges that upon the issuance thereof, and until such time as the same is no longer required under the
applicable securities laws and regulations, certificates or book entry forms evidencing the Shares will bear a legend in substantially
the following form:

 

THE
SECURITIES REPRESENTED BY THE SHARES HAVE BEEN OFFERED IN AN OFFSHORE TRANSACTION TO A PERSON WHO IS NOT A U.S. PERSON (AS DEFINED
HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”).

 

[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE] HAS NOT BEEN REGISTERED UNDER THE ACT, OR ANY U.S.
STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR
TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE ACT, PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING
THIS SECURITY [AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY] MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE
ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE ACT.

 

8.2
The Investor hereby acknowledges and agrees to the Company making a notation on its records in order to implement the restrictions
on transfer set forth and described in this Subscription Agreement.

 

9.
Costs

 

The
Investor acknowledges and agrees that all costs and expenses incurred by the Investor (including any fees and disbursements of
any counsel or other professional retained by the Investor) relating to the purchase of the Shares will be borne solely by the
Investor.

 

10.
Governing Law

 

This
Subscription Agreement is governed by the laws of the State of New York, without regard to the conflict of laws provisions thereof.
The Investor, in his personal or corporate capacity and, if applicable, on behalf of each beneficial purchaser for whom it is
acting, irrevocably agrees to the jurisdiction of the courts of the State of New York and each Subscriber and the Company waive
any right to a jury trial thereof

 

11.
Survival

 

This
Subscription Agreement, including without limitation the representations, warranties and covenants contained herein, will survive
and continue in full force and effect and be binding upon the parties hereto notwithstanding the completion of the purchase of
the Shares by the Investor pursuant hereto.

 

12.
Assignment

 

This
Subscription Agreement is transferable or assignable only with the prior written consent of the Company, which consent will not
be unreasonably denied. Furthermore, except as otherwise expressly limited herein, the provisions hereof shall inure to the benefit
of, and be binding upon, the transferees, successors, assigns, heirs, executors, and administrators of the parties hereto.

 

    	 

    	 

    

 

13.
Severability

 

The
invalidity or unenforceability of any particular provision of this Subscription Agreement will not affect or limit the validity
or enforceability of the remaining provisions of this Subscription Agreement and the remainder of this Subscription Agreement
shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms; provided, however,
that in such event this Subscription Agreement shall be interpreted so as to give effect, to the greatest extent consistent with
and permitted by applicable law, to the meaning and intention of the excluded provision as determined by such court of competent
jurisdiction.

 

14.
Entire Agreement; Amendment

 

Except
as expressly provided in this Subscription Agreement and in the agreements, instruments and other documents contemplated or provided
for herein, this Subscription Agreement contains the entire agreement between the parties with respect to the sale of the Shares.
The Company makes and has given no other warranties or representations, other than as expressly contained herein. Any term of
this Subscription Agreement may be amended and the observance of any term hereof may be waived (either prospectively or retroactively
and either generally or in a particular instance) only with the written consent of the Company and the Investor.

 

15.
Notices

 

All
notices here under will be in writing and will be deemed to have been duly given if mailed or transmitted by any standard form
of telecommunication. Notices to the Investor will be directed to the address on the Investor’s signature page and notices
to the Company will be directed to it at the address first set forth above unless another address will be provided to the Investor
by the Company in writing.

 

16.
Counterparts and Electronic Means

 

This
Subscription Agreement may be executed in any number of counterparts, each of which, when so executed and delivered, will constitute
an original and all of which together will constitute one instrument. Delivery of an executed copy of this Subscription Agreement
by electronic facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed
to be execution and delivery of this Subscription Agreement as of the date hereinafter set forth.

 

    	 

    	 

    

 

IN
WITNESS WHEREOF the Investor has duly executed this Subscription Agreement as of the date of acceptance by the Company.

 

	[_________]	 
	(Name
    of Investor)	 
	 	 
	____________________	 
	(Signature
    of Investor)	 
	 	 
	[_________]	 
	(Address
    of Investor)	 

 

[Signature
Page – Subscription Agreement August 2019]

 

    	 

    	 

    

 

A
C C E P T A N C E

 

The
above-mentioned Subscription Agreement in respect of the Shares is hereby accepted by TechCare Corp. 

 

DATED
this __ day of August, 2019

 

TechCare
Corp.

 

	By:	/s/
    Zvi Yemini	 
	Name: 	Zvi
        Yemini

        
	 
	Title:	CEO	 

 

    	 

    	 

    

 

Exhibit
A

 

Certificate
of DesignationEX-10.1

 Exhibit 10.1 

FAIR ISAAC CORPORATION 

TRANSITION AND SEPARATION AGREEMENT 

WITH STUART C. WELLS 

THIS TRANSITION AND SEPARATION AGREEMENT (the “Agreement”) is made and entered into as of August 21, 2019 (the “Effective
Date”) by and between Fair Isaac Corporation, a Delaware corporation (the “Company”), and Stuart C. Wells, a resident of California (“Executive”). 

BACKGROUND 

A.    Executive began his employment with the Company in 2012 and currently serves as the Company’s Executive Vice
President, Chief Technology Officer. 
 B.    The Company and Executive entered into a letter agreement dated
April 24, 2012 (the “Letter Agreement”). 
 C.    The Company and Executive entered into a Management
Agreement dated April 25, 2012, as amended by an Amendment to Management Agreement dated April 21, 2014 and a Second Amendment to Management Agreement dated May 10, 2016 (the “Management Agreement”). 

D.    The Company and Executive are parties to a PIIA and Indemnification Agreement (as such terms are defined in the
Letter Agreement). 
 E.    As of the Effective Date, Executive holds options to purchase shares of common stock of the
Company and holds restricted stock unit awards, performance share unit awards, and market share unit awards pursuant to written option agreements, restricted stock unit agreements, performance share unit agreements, and market share unit agreements
as applicable (the “Equity Awards”), as summarized in the attached Exhibit A to this Agreement. 

F.    Executive has announced that he intends to separate from the Company effective December 31, 2019 (the
“Separation Date”). 
 G.    The parties have agreed that following the Effective Date Executive shall remain
employed with the Company and otherwise provide services to the Company under the terms of this Agreement in order to facilitate a smooth transition for the Company. 

NOW THEREFORE, in consideration of the mutual promises and provisions contained in this Agreement, the parties, intending to be legally bound,
agree as follows: 
 AGREEMENT 

1.    Separation. Executive hereby confirms his resignation as the Executive Vice President, Chief
Technology Officer and as an officer of the Company and any of its subsidiaries 

  
 1 

 
and affiliates, effective as of the Effective Date. Executive further confirms his separation and resignation as an employee of the Company and any of its subsidiaries and affiliates, effective
as of the Separation Date. Executive’s employment with the Company will automatically terminate effective as of the Separation Date, unless earlier terminated in accordance with subparagraph 2(d) below. The period of Executive’s employment
hereunder is referred to in this Agreement as the “Transition Term”. Executive shall not have any other employment or engage in any other business venture during the Transition Term. 

2.    Employment Terms During Transition. 

(a)    Scope of Engagement. Subject to the terms and conditions of this Agreement, Executive agrees to remain in the
employ of the Company, and the Company agrees to continue Executive’s employment, for the duration of the Transition Term. During the Transition Term, Executive shall report to the Company’s Chief Executive Officer or his designee and
shall hold the title of Vice President, Technology Strategy of the Company. As Vice President, Technology Strategy, Executive’s duties and responsibilities shall include transition assistance and special project matters as may be requested by
the Company’s Chief Executive Officer (“Transition Services”). 
 (b)    Pay, Equity and Benefits.
During the Transition Term, the Company will pay Executive a base salary at the same base salary rate in effect for Executive on the Effective Date, subject to normal withholdings and payable in accordance with the Company’s normal payroll
practices. In addition, during the Transition Term Executive shall participate in such employee benefit plans and programs for which he may be eligible and in which he participated on the Effective Date, including the Company’s Management
Incentive Plan through September 30, 2019, pursuant to the terms and conditions of such plans; provided, however, that, except with respect to Executive’s continued participation in the Management Incentive Plan through September 30,
2019 (and Executive’s receipt of any payment under the Management Incentive Plan related to such continued participation), Executive shall not be eligible for any incentive, bonus, options, restricted stock unit awards, performance share unit
awards, market share unit awards, or other compensation awards during the Transition Term. Executive agrees that consistent with the Company’s policy he does not accrue any vacation leave and will not accrue any vacation leave during the
Transition Term and therefore he will not be entitled to any payment for vacation leave upon conclusion of the Transition Term. 

(c)    Expenses. The Company shall reimburse Executive for all reasonable and necessary out-of-pocket business, travel and entertainment expenses incurred by him in the performance of his duties and responsibilities for the Company during the Transition Term,
subject to the Company’s normal policies and procedures for expense verification and documentation. 

(d)    Early Termination. Notwithstanding anything in this Agreement to the contrary, Executive’s employment
hereunder continues to be at-will and may be terminated before the Separation Date (1) by the Company for any reason, including without limitation Cause (as such term is defined in the Letter
Agreement or the Management Agreement, as 

  
 2 

 
applicable), (2) by Executive for any reason in accordance with the Letter Agreement or the Management Agreement (except that any of the terms of this Agreement do not support an involuntary
termination or resignation for Good Reason (as such term is defined in the Letter Agreement or the Management Agreement, as applicable)), or (3) by the Company or Executive for any reason following an Event (as defined in the Management
Agreement). The Company and Executive acknowledge and agree, if the Company terminates his employment for any reason prior to the Separation Date, Executive shall not be entitled to any additional compensation or benefits from the Company (including
without limitation those outlined in this Agreement), unless Executive is specifically entitled to any pay or benefits based on such termination under the terms of the Letter Agreement or the Management Agreement. . 

(e)    Coordination With Management Agreement. The parties agree that (1) if any Event shall occur
during the Term (as such term is defined in the Management Agreement), and the employment of Executive with the Company is voluntarily or involuntarily terminated under circumstances specified in Section 2(a) of the Management Agreement, then
Executive shall be eligible to receive from the Company or its successor the benefits under Section 2 of the Management Agreement in accordance with the terms of the Management Agreement; and (2) neither Executive’s notice of
resignation from his position as Executive Vice President, Chief Technology Officer effective as of the Effective Date, his resignation from employment effective as of the Separation Date, nor his resignation effective as of the Separation Date,
both in accordance with paragraph 1, constitute an involuntary termination or resignation for Good Reason (as such term is defined in the Management Agreement), or otherwise triggers any payments or benefits, under the Management Agreement or the
Letter Agreement. 
 3.    Equity Awards. Executive acknowledges and agrees that the
spreadsheet set forth as Exhibit A is an accurate list of all unearned or unvested equity-based awards received by Executive during his employment with the Company. The Equity Awards shall continue to be governed by the terms and conditions set
forth in the applicable written option agreements, restricted stock unit agreements, performance share unit agreements, and market share unit agreements. For the avoidance of doubt, Executive acknowledges (1) that any unearned and unvested
holdings will be forfeited upon the Separation Date, (2) any vested, non-qualified stock options must be exercised within 90 calendar days following the Separation Date, per the terms of existing grant
agreements. 
 4.    Confidential Information. Executive acknowledges entering into the PIIA
(as defined in the Letter Agreement) and hereby reaffirms his commitments and obligations under the PIIA. Nothing in this Agreement is intended to modify, amend, cancel or supersede the PIIA in any manner. 

  
 3 

 5.    Confidentiality. 

(a)    General Standard. The provisions of this Agreement, (collectively “Confidential Transition
Information”) will be treated by Executive and the Company as confidential. Accordingly, Executive and the Company will not disclose Confidential Transition Information to anyone at any time, except as provided in subparagraph 5(b) below. 

(b)    Exceptions. 

(i)    It will not be a violation of this Agreement for Executive to disclose Confidential Transition Information to his
immediate family, his attorneys, his accountants or tax advisors, or his financial planners. It will not be a violation of this Agreement for the Company to disclose Confidential Transition Information to its directors, officers, employees or agents
in the course of performing their responsibilities for the Company, or as otherwise necessary for legitimate business purposes. 

(ii)    It will not be a violation of this Agreement for Executive to inform prospective future employers or partners
about Executive’s post-employment restrictions and continuing obligations to the Company. 
 (iii)    It will not
be a violation of this Agreement for Executive or the Company to disclose Confidential Transition Information pursuant to a legally enforceable subpoena, deposition notice, or other legal process, so long as before any disclosure is made, such party
first notifies the other party and provides such other party with sufficient time to seek a protective order with respect to such Confidential Transition Information. 

(iv)    It will not be a violation of this Agreement for Executive or the Company to disclose Confidential Transition
Information in reports to governmental agencies as required by law, including but not limited to disclosure as required by federal securities laws and regulations or to any federal or state tax or securities regulator. 

6.    Records, Documents, and Property. Executive acknowledges and represents that he will
deliver to the Company on or before the conclusion of the Transition Term any and all Company records and any and all Company property in his possession or under his control, including without limitation, manuals, books, blank forms, documents,
letters, memoranda, notes, notebooks, reports, printouts, computer disks, computer tapes, data, tables, or calculations and all copies thereof, documents that in whole or in part contain any trade secrets or confidential, proprietary, or other
secret information of the Company and all copies thereof, and keys, access cards, access codes, source codes, passwords, credit cards, personal computers, telephones, and other electronic equipment belonging to the Company. Executive agrees to
return to the Company any and all Company property that may be provided to him by the Company during the Transition Term immediately upon the end of the Transition Term, or at such earlier time as the Company may request. Nothing in this paragraph 6
is intended to preclude Executive from keeping documents that are related solely to his compensation, benefits, rights, and other perquisites of being an officer and/or employee of the Company and/or its subsidiaries. 

  
 4 

 7.    Indemnification. The Company will
indemnify Executive in connection with Executive’s status, duties and responsibilities for the Company, as set out in the Indemnification Agreement (as defined in the Letter Agreement). Executive states that he has no knowledge of any
wrongdoing on the part of the Company or its directors, officers, employees or agents. 

8.    Cooperation. 

(a)    Agreement to Assist and Cooperate. At the Company’s reasonable request and upon reasonable
notice, Executive will, from time to time and without further consideration, during and following the Transition Term, timely execute and deliver such acknowledgements, instruments, certificates, and other ministerial documents (including without
limitation, certification as to specific actions performed by Executive in his capacity as an officer of the Company) as may be necessary or appropriate to formalize and complete the applicable corporate records. In addition, at the Company’s
reasonable request and upon reasonable notice, Executive will, from time to time and without further consideration, during and following the Transition Term discuss and consult with the Company regarding business matters that he was directly and
substantially involved with while employed by or otherwise providing services to the Company. 
 (b)    Claims
Involving the Company. Executive agrees that he will, at any future time, be available upon reasonable notice from the Company, with or without subpoena, to be interviewed, review documents or things, give depositions, testify, or engage in
other reasonable activities in connection with any litigation or investigation, with respect to matters that Executive has or may have knowledge of by virtue of his employment by or service to the Company or any related entity. In performing his
obligations under this subparagraph 8(b) to testify or otherwise provide information, Executive will honestly, truthfully, forthrightly, and completely provide the information requested. Executive will comply with this Agreement upon notice from the
Company that the Company or its attorneys believe that his compliance would be helpful in the resolution of an investigation or the prosecution or defense of claims. 

(c)    Payment. In the event that Executive’s services under subparagraphs 8(a) or 8(b) exceed five
(5) hours in any calendar month following the conclusion of the Transition Term, the Company shall compensate Executive for such additional services at the hourly rate of $200.00. 

9.    Non-disparagement. Both Executive and the Company
(together the “Parties” or “Party”) will not malign, defame, or disparage the reputation, character, image, products, or services of either Party. Further, Executive will not malign, defame, or disparage the reputation or
character of the Company’s directors, officers, employees, or agents. It shall not be considered disparagement and nothing in this Agreement is intended to prevent or interfere with Executive or Company making any required or reasonable
communications with, or providing information to, any governmental, law enforcement, or stock exchange agency or representative, or in connection with any governmental investigation, court, administrative or arbitration proceeding. 

  
 5 

 10.    Taxes. The Company may take such
action as it deems appropriate to ensure that all applicable federal, state, city and other payroll, withholding, income or other taxes arising from any compensation, benefits or any other payments made pursuant to this Agreement, and in order to
comply with all applicable federal, state, city and other tax laws or regulations, are withheld or collected from Executive. This Agreement is intended to satisfy or be exempt from the requirements of Section 409A(a)(2), (3) and (4) of the
Internal Revenue Code of 1986, as amended including current and future guidance and regulations interpreting such provisions (the (“Code”). Executive acknowledges and agrees that the Company has made no assurances or representations to him
regarding the tax treatment of any consideration provided for in this Agreement and that the Company has advised him to obtain his own personal tax advice. Except for any tax amounts withheld by the Company from the payments or other consideration
hereunder and any employment taxes required to be paid by the Company, Executive shall be responsible for payment of any and all taxes owed in connection with the consideration provided for in this Agreement. 

11.    Assignment and Successors. The rights and obligations of the Company under this Agreement
shall inure to the benefit of and shall be binding upon the successors and assigns of the Company. Executive may not assign this Agreement or any rights or obligations hereunder. Any purported or attempted assignment or transfer by Executive of this
Agreement or any of Executive’s duties, responsibilities, or obligations hereunder shall be void. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of its business and/or assets to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this
Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise. 

12.    Notices. For purposes of this Agreement, notices provided in this Agreement shall be in
writing and shall be deemed to have been given when personally served, sent by courier or mailed by United States registered or certified mail, return receipt requested, postage prepaid, to the last known residence address of Executive as stated in
the employment records of the Company or, in the case of the Company, to its principal office, to the attention of the Company’s Chief Executive Officer and the Company’s General Counsel, or to such other address as either party may have
furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 

13.    Construction and Severability. In the event any provision of this Agreement shall be held
illegal or invalid for any reason, said illegality or invalidity will not in any way affect the legality or validity of any other provision hereof. 

  
 6 

 14.    Remedies. Executive acknowledges that
it would be difficult to fully compensate the Company for monetary damages resulting from any breach by him of the provisions paragraphs 4, 5 or 6 of this Agreement. Accordingly, in the event of any actual or threatened breach of any such
provisions, the Company shall, in addition to any other remedies it may have, be entitled to injunctive and other equitable relief to enforce such provisions, and such relief may be granted without the necessity of proving actual monetary damages.

 15.    Entire Agreement. This Agreement sets forth the entire agreement between the Company and
Executive with respect to his employment by the Company, the termination of such employment, and the Transition Term, and there are no undertakings, covenants, or commitments other than as set forth in this Agreement, the written agreements
applicable to the Equity Awards, the Letter Agreement, the Management Agreement, the PIIA, Indemnification Agreement, and any qualified employee benefit plans sponsored by the Company in which Executive is a participant. This Agreement may not be
altered or amended, except by a writing executed by the party against whom such alteration or amendment is to be enforced. 

16.    Counterparts. This Agreement may be simultaneously executed in any number of counterparts, and
such counterparts executed and delivered, each as an original, shall constitute but one and the same instrument. 

17.    Captions and Headings. The captions and paragraph headings used in this Agreement are for
convenience of reference only, and shall not affect the construction or interpretation of this Agreement or any of the provisions hereof. 

18.    Survival. The parties expressly acknowledge and agree that the provisions of this Agreement
which by their express or implied terms extend beyond the termination of Executive’s employment hereunder, including without limitation paragraphs 4, 5 or 6 of this Agreement shall continue in full force and effect, notwithstanding the
conclusion of the Transition Term. In addition, the representations and warranties contained herein shall survive the execution and delivery hereof and the consummation of the transactions contemplated hereby. 

19.    Waivers. No failure on the part of either party to exercise, and no delay in exercising, any
right or remedy hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right or remedy hereunder preclude any other or further exercise thereof, or the exercise of any other right or remedy granted hereby or by
any related document or by law. No single or partial waiver of rights or remedies hereunder, nor any course of conduct of the parties, shall be construed as a waiver of rights or remedies by either party (other than as expressly and specifically
waived). Any waiver of rights or obligations hereunder shall be in writing signed by the waiving party. 
 [signature page follows]

  
 7 

 IN WITNESS WHEREOF, the parties have signed this Transition and Separation Agreement
as of the date set forth above. 
  

							
	FAIR ISAAC CORPORATION	 		 	STUART C. WELLS
				
	By:	 	 /s/ Mark R. Scadina
	 		 	 /s/ Stuart C. Wells

		 	Mark R. Scadina	 	            	 	Signature
		 	 Its   Executive Vice President, General Counsel and Corporate
Secretary
	 		 	

  
 8 

 Exhibit A 

Long-Term Incentive Awards with Unvested or Unearned Status 

(As of August 20, 2019) 
  

																							
	 Grant

Number
	  	 Type
	  	 Grant Date
	  	Targeted
Shares
Granted	 	  	 PSU
Performance
Factor

	  	 PSUs Earned
	  	 MSU Period
1 Earnings
	  	 MSU Period
2 Earnings
	  	Shares Unvested or
Unearned
(August 19, 2019)	 	  	 Notes

	P170007	  	PSU	  	12/8/2016	  	 	7,268	 	  	175.625%	  	12,765	  		  		  	 	4,255	 	  	(1)
	P180007	  	PSU	  	12/8/2017	  	 	5,488	 	  	200.000%	  	10,976	  		  		  	 	7,317	 	  	(2)
	P190007	  	PSU	  	12/10/2018	  	 	5,300	 	  	TBD	  	TBD	  		  		  	 	5,300	 	  	(3)
	M170007	  	MSU	  	12/8/2016	  	 	7,268	 	  		  		  	2,859	  	4,846	  	 	TBD	 	  	(4)
	M180007	  	MSU	  	12/8/2017	  	 	5,488	 	  		  		  	3,312	  	TBD	  	 	TBD	 	  	(5)
	M190007	  	MSU	  	12/10/2018	  	 	5,300	 	  		  		  	TBD	  		  	 	TBD	 	  	(6)
	RU011124	  	RSU	  	12/8/2015	  	 	6,846	 	  		  		  		  		  	 	1,711	 	  	
	RU011938	  	RSU	  	12/8/2016	  	 	7,268	 	  		  		  		  		  	 	3,634	 	  	
	RU012830	  	RSU	  	12/8/2017	  	 	5,488	 	  		  		  		  		  	 	4,116	 	  	
	RU016285	  	RSU	  	12/10/2018	  	 	5,300	 	  		  		  		  		  	 	5,300	 	  	

 Notes: 
  

	(1)	 Reflects 7,268 targeted PSUs granted x 175.625% performance factor. Final tranche of 4,255 units will vest
12/8/19. 

	(2)	 Reflects 5,488 targeted PSUs granted x 200% performance factor. Next tranche of 3,659 units will vest on
12/8/19. 

	(3)	 Reflects 5,300 targeted PSUs granted. FY19 performance factor yet to be determined. 1st tranche will vest on
12/10/19. 

	(4)	 Period 3 earnings yet to be determined and will be equal to 3 year earnings less units earned in Periods 1 and
2 with those units vesting on 12/8/19. 

	(5)	 Period 2 earnings yet to be determined with those units vesting on 12/8/19. 

	(6)	 Period 1 earnings yet to be determined with those units vesting 12/10/19. 

  
 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]